BioEclipse Therapeutics (Series A-1)

Funding Details
Awarder
Inbox
Date Award
June 25, 2019
Vertical
Biopharmaceuticals
Funding URL
View Funding Page
Funding Amount:
$7,700,000

Company Info
Organizations Involved
Johnson & Johnson Innovation
Founders
Pamela Contag
Company Description
BioEclipse Therapeutics is a clinical-stage oncology company that develops immuno-oncology therapeutics using its proprietary technology.
Market
Cancer treatment
Location
South San Francisco, California, USA
Coinvestors
DEFTA Partners, Plum Alley Investments, Revelis Capital Group, TEEC Angel Fund, Tsingyuan Ventures

Links